I see the point you are making, but for any drug that someone takes for a long time for MS, the relative reduction seems relevant. A 33% reduction in relapses means two relapses in three years instead of three relapses in three years...that is if we make the possibly quite incorrect assumption that the drugs have approximately the same effect on everyone who takes it.